122 related articles for article (PubMed ID: 24608634)
1. Generation of major human excretory and circulating drug metabolites using a hepatocyte relay method.
Ballard TE; Orozco CC; Obach RS
Drug Metab Dispos; 2014 May; 42(5):899-902. PubMed ID: 24608634
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites.
Wang WW; Khetani SR; Krzyzewski S; Duignan DB; Obach RS
Drug Metab Dispos; 2010 Oct; 38(10):1900-5. PubMed ID: 20595376
[TBL] [Abstract][Full Text] [Related]
3. Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists.
Hutzler JM; Ring BJ; Anderson SR
Drug Metab Dispos; 2015 Dec; 43(12):1917-28. PubMed ID: 26363026
[TBL] [Abstract][Full Text] [Related]
4. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.
Dalvie D; Obach RS; Kang P; Prakash C; Loi CM; Hurst S; Nedderman A; Goulet L; Smith E; Bu HZ; Smith DA
Chem Res Toxicol; 2009 Feb; 22(2):357-68. PubMed ID: 19146377
[TBL] [Abstract][Full Text] [Related]
5. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
[TBL] [Abstract][Full Text] [Related]
6. Application of a Micropatterned Cocultured Hepatocyte System To Predict Preclinical and Human-Specific Drug Metabolism.
Ballard TE; Wang S; Cox LM; Moen MA; Krzyzewski S; Ukairo O; Obach RS
Drug Metab Dispos; 2016 Feb; 44(2):172-9. PubMed ID: 26608083
[TBL] [Abstract][Full Text] [Related]
7. Further Assessment of the Relay Hepatocyte Assay for Determination of Intrinsic Clearance of Slowly Metabolised Compounds Using Radioactivity Monitoring and LC-MS Methods.
Murgasova R
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):817-826. PubMed ID: 31422548
[TBL] [Abstract][Full Text] [Related]
8. Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.
Jian W; Xu Y; Edom RW; Weng N
Bioanalysis; 2011 Apr; 3(8):899-912. PubMed ID: 21510763
[TBL] [Abstract][Full Text] [Related]
9. A novel relay method for determining low-clearance values.
Di L; Trapa P; Obach RS; Atkinson K; Bi YA; Wolford AC; Tan B; McDonald TS; Lai Y; Tremaine LM
Drug Metab Dispos; 2012 Sep; 40(9):1860-5. PubMed ID: 22645091
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system.
Darnell M; Ulvestad M; Ellis E; Weidolf L; Andersson TB
J Pharmacol Exp Ther; 2012 Oct; 343(1):134-44. PubMed ID: 22776955
[TBL] [Abstract][Full Text] [Related]
11. A new in vitro approach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations.
Lahoz A; Donato MT; Montero S; Castell JV; Gómez-Lechón MJ
Rapid Commun Mass Spectrom; 2008; 22(2):240-4. PubMed ID: 18088071
[TBL] [Abstract][Full Text] [Related]
12. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening.
Prot JM; Videau O; Brochot C; Legallais C; Bénech H; Leclerc E
Int J Pharm; 2011 Apr; 408(1-2):67-75. PubMed ID: 21295126
[TBL] [Abstract][Full Text] [Related]
13. Micropatterned coculture of hepatocytes on electrospun fibers as a potential in vitro model for predictive drug metabolism.
Liu Y; Wei J; Lu J; Lei D; Yan S; Li X
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():475-84. PubMed ID: 27040241
[TBL] [Abstract][Full Text] [Related]
14. Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites.
Kostrubsky SE; Strom SC; Ellis E; Nelson SD; Mutlib AE
Chem Res Toxicol; 2007 Oct; 20(10):1503-12. PubMed ID: 17900172
[TBL] [Abstract][Full Text] [Related]
15. Assessment of chimeric mice with humanized liver as a tool for predicting circulating human metabolites.
Kamimura H; Nakada N; Suzuki K; Mera A; Souda K; Murakami Y; Tanaka K; Iwatsubo T; Kawamura A; Usui T
Drug Metab Pharmacokinet; 2010; 25(3):223-35. PubMed ID: 20610881
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of metabolic drug-drug interactions: a descriptive and critical commentary.
Li AP
Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.25. PubMed ID: 23045147
[TBL] [Abstract][Full Text] [Related]
17. A practical strategy for characterization of the metabolic profile of chiral drugs using combinatory liquid chromatography-mass spectrometric techniques: application to tetrahydropalmatine enantiomers and their metabolites in rat urine.
Zhang Y; Dong X; Le J; Wen J; Lin Z; Liu Y; Lou Z; Chai Y; Hong Z
J Pharm Biomed Anal; 2014 Jun; 94():152-62. PubMed ID: 24598170
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry.
Suchanova B; Kostiainen R; Ketola RA
Eur J Pharm Sci; 2008 Jan; 33(1):91-9. PubMed ID: 18055188
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Metabolism of Slowly Cleared G Protein-Coupled Receptor 139 Agonist TAK-041 Using Rat, Dog, Monkey, and Human Hepatocyte Models (HepatoPac): Correlation with In Vivo Metabolism.
Kamel A; Bowlin S; Hosea N; Arkilo D; Laurenza A
Drug Metab Dispos; 2021 Feb; 49(2):121-132. PubMed ID: 33273044
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Biotransformation of Low-Turnover Drugs in the H
Burton RD; Hieronymus T; Chamem T; Heim D; Anderson S; Zhu X; Hutzler JM
Drug Metab Dispos; 2018 Nov; 46(11):1617-1625. PubMed ID: 30135244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
